膜性肾病合并肺栓塞一例并文献复习
Membranous Nephropathy Complicated with Pulmonary Embolism: A Case Report and Literature Review
DOI: 10.12677/ACM.2021.113160, PDF,  被引量    科研立项经费支持
作者: 刘 媛, 解秀荣:青岛大学医学部,山东 青岛;单文红, 黄俊彦, 许颖川, 季文萱*:青岛大学第二临床医学院肾内科,山东 青岛
关键词: 膜性肾病肾病综合征肺动脉栓塞高凝溶栓病例报告Membranous Nephropathy Nephrotic Syndrome Pulmonary Embolism Hypercoagulability Thrombolysis Case Report
摘要: 目的:探讨膜性肾病的诊治特点,引起临床医师对膜性肾病相关血栓事件疾病的关注。方法:报告1例我院收治的确诊为膜性肾病合并肺动脉栓塞病人的诊断和治疗过程,并复习相关文献。结果:患者此次伴有胸闷憋气症状,3年前曾有类似发病史,此次最终确诊为肺动脉栓塞,经过抗凝溶栓治疗,肺动脉仍有残余血栓,但胸闷症状明显好转出院。结论:膜性肾病患者出现活动后胸闷憋气症状时,要警惕肺动脉栓塞可能性,必要时行肺动脉CTA可明确诊断。
Abstract: Objective: To investigate the characteristics of diagnosis and treatment of membranous nephropathy and to arouse clinicians’ attention to thrombotic events related to membranous nephropathy. Methods: This article reported the diagnosis and treatment of a patient with membranous nephropathy complicated with pulmonary embolism, and related articles were reviewed. Results: The patient was accompanied with chest tightness and suffocation symptoms, and had a similar history 3 years ago, and was finally diagnosed as pulmonary embolism. After anticoagulation and thrombolytic therapy, the pulmonary artery still had residual thrombus, but the chest tightness symptoms significantly improved, then the patient was discharged. Conclusion: When patients with membranous nephropathy have symptoms of chest tightness and shortness of breath after exercise, we should be aware of the possibility of pulmonary embolism, and pulmonary artery CTA can make a definite diagnosis if necessary.
文章引用:刘媛, 单文红, 黄俊彦, 许颖川, 解秀荣, 季文萱. 膜性肾病合并肺栓塞一例并文献复习[J]. 临床医学进展, 2021, 11(3): 1119-1124. https://doi.org/10.12677/ACM.2021.113160

参考文献

[1] Couser, W.G. (2017) Primary Membranous Nephropathy. Clinical Journal of the American Society of Nephrology: CJASN, 12, 983-997. [Google Scholar] [CrossRef
[2] Al-Azzawi, H.F., Obi, O.C., Safi, J., et al. (2016) Nephrotic Syndrome-Induced Thromboembolism in Adults. International Journal of Critical Illness and Injury Science, 6, 85-88. [Google Scholar] [CrossRef] [PubMed]
[3] Kerlin, B.A., Ayoob, R. and Smoyer, W.E. (2012) Epidemiology and Pathophysiology of Nephrotic Syndrome-Associated Thromboembolic Disease. Clinical Journal of the American Society of Nephrology: CJASN, 7, 513-520. [Google Scholar] [CrossRef
[4] Zou, P.M., Li, H., Cai, J.F., et al. (2018) A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy. Chinese Medical Sciences Journal, 33, 91-99. [Google Scholar] [CrossRef
[5] 中华医学会呼吸病学分会肺栓塞与肺血管病学组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087.
[6] Rankin, A.J., McQuarrie, E.P., Fox, J.G., et al. (2017) Venous Thromboembolism in Primary Nephrotic Syndrome—Is the Risk High Enough to Justify Prophylactic Anticoagulation? Nephron, 135, 39-45. [Google Scholar] [CrossRef] [PubMed]
[7] Agrawal, S., Zaritsky, J.J., Fornoni, A., et al. (2018) Dyslipidaemia in Nephrotic Syndrome: Mechanisms and Treatment. Nature Reviews Nephrology, 14, 57-70. [Google Scholar] [CrossRef] [PubMed]
[8] Zhu, H., Han, Q., Zhang, D., et al. (2018) The Clinicopathological Features of Patients with Membranous Nephropathy. International Journal of Nephrology and Renovascular Disease, 11, 33-40. [Google Scholar] [CrossRef
[9] Uncanin, S., Dzemidzic, J., Serdarevic, N., et al. (2020) Idiopathic Membranous Nephropathy and Treatment Related Complications. Medical Archives (Sarajevo, Bosnia and Herzegovina), 74, 228-232. [Google Scholar] [CrossRef] [PubMed]
[10] Lin, R., McDonald, G., Jolly, T., et al. (2020) A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome. Kidney International Reports, 5, 435-447. [Google Scholar] [CrossRef] [PubMed]